RECIST 1.1 – Standardisation and disease-specific adaptations: Perspectives from the RECIST Working Group
European Journal of Cancer2016Vol. 62, pp. 138–145
Citations Over TimeTop 1% of 2016 papers
Lawrence H. Schwartz, Lesley Seymour, Saskia Litière, Robert Ford, Stephen J. Gwyther, Sumithra J. Mandrekar, Lalitha Shankar, Jan Bogaerts, Alice P. Chen, Janet Dancey, Wendy Hayes, F. Stephen Hodi, Otto S. Hoekstra, Erich P. Huang, Nancy U. Lin, Yi Yan, Patrick Therasse, Jedd D. Wolchok, Elisabeth G.E. de Vries
Related Papers
- → Magnetic resonance imaging-based deep learning imaging biomarker for predicting functional outcomes after acute ischemic stroke(2024)9 cited
- → Digital Validation in Breast Cancer Needle Biopsies: Comparison of Histological Grade and Biomarker Expression Assessment Using Conventional Light Microscopy, Whole Slide Imaging, and Digital Image Analysis(2024)4 cited
- → Evaluation of an imaging biomarker, Dixon quantitative chemical shift imaging, in Gaucher disease: lessons learned(2014)20 cited
- → Inter-tumor validation, through advanced MRI and circulating biomarkers, of plasma Tie2 as the vascular response biomarker for bevacizumab.(2017)
- → P1‐042: SUPPORTING DISEASE MODIFYING THERAPIES VIA ANALYSES OF THE LINK BETWEEN CLINICAL ENDPOINTS AND BIOMARKERS IN ALZHEIMER'S DISEASE CLINICAL TRIALS(2018)